PharmaTrail AG provides blockchain-based software solutions for the pharmaceutical, biotech, and medtech sectors, focusing on clinical trial data management, integrity, and security through its end-to-end platform, Lucie.
PharmaTrail AG is a Swiss-based technology company founded in 2020 that develops blockchain-powered software solutions for clinical trial data management. The company provides a comprehensive, end-to-end platform marketed under the name Lucie, which includes core modules such as Electronic Data Capture (EDC), eConsent, and ePRO/eCOA. By anchoring critical clinical data on an incorruptible ledger, the platform aims to provide a tamper-proof audit trail that enhances data integrity, security, and traceability throughout the research lifecycle. The system is designed to be user-centered and intuitive, replacing legacy systems to improve efficiency from study setup to final data export.
The platform addresses persistent industry challenges regarding regulatory compliance, data transparency, and the high cost of repeating trials due to unverifiable accuracy. By ensuring that clinical data can be trusted without question, PharmaTrail supports pharmaceutical, biotechnology, and medical technology companies in accelerating their research processes and business transactions. The company maintains an active presence in the digital health ecosystem, including membership in the Flying Health network, and provides mobile applications to facilitate patient participation and informed consent in clinical studies. Its solutions are developed to comply with global standards, including GDPR, HIPAA, 21 CFR Part 11, and EU Annex 11.